Multidrug Resistance Associated Protein 1 (ABCC1) Antibody

Documentos del producto

Especificaciones del producto

Primary Antibodies

Target: Multidrug Resistance Associated Protein 1 (ABCC1)

Mouse

Human

WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.

Monoclonal

Unconjugated

Purified by Protein A and Protein G affinity chromatography.

1 ml

Liquid

WB, IHC, IF/ICC

0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.

Please enquire.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

ABC29,ABCC,DFNA77,GS-X,MRP,MRP1

Antibody anti-ABCC1

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

ABCC1, also known as multidrug resistance-associated protein 1 (MRP1), is a transmembrane ATP-binding cassette transporter that effluxes a wide range of substrates, including drugs, xenobiotics, and endogenous molecules such as glutathione, leukotrienes, and conjugated metabolites. It is highly expressed in barrier tissues, such as the blood-brain barrier, lungs, and liver, where it protects cells by exporting potentially toxic compounds. ABCC1 plays a key role in multidrug resistance, as its overexpression in cancer cells reduces the efficacy of chemotherapeutic agents by actively transporting them out of cells. Structurally, ABCC1 contains two transmembrane domains and two ATP-binding domains that enable ATP-driven substrate transport. Dysregulation of ABCC1 activity is implicated in various pathological conditions, including drug resistance, inflammation, and oxidative stress, making it a target for therapeutic intervention in oncology and pharmacology.